OptimizeRx Corp — Director's Dealing 2021

Aug 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-08-20

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-20	Common Stock (pursuant to 10B5-1 plan)	S	5000	$58.45	Disposed	58796	Direct
2021-08-24	Common Stock (pursuant to 10B5-1 plan)	S	4000	$61.50	Disposed	54796	Direct

Footnotes

F1: These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.